TYRA
Tyra Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.73
+5.32%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.66
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$0.69
- EPS estimate
- -$0.65
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -0.4%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $42
- PT range
- $30 – $53
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.65 | -$0.69 | Miss -6.17% | — |
| May 13, 2026 | -$0.60 | -$0.64 | Miss -6.67% | — |
| Nov 5, 2025 | -$0.50 | -$0.50 | In line | — |
| Aug 14, 2025 | -$0.53 | -$0.47 | Beat 11.32% | — |
| May 8, 2025 | -$0.49 | -$0.47 | Beat 4.08% | — |
| Mar 27, 2025 | -$0.48 | -$0.43 | Beat 10.42% | — |
| Nov 7, 2024 | -$0.40 | -$0.41 | Miss -2.50% | — |
| May 9, 2024 | -$0.46 | -$0.35 | Beat 23.91% | — |
| Mar 19, 2024 | -$0.48 | -$0.53 | Miss -10.42% | $502.0K |
| Aug 10, 2023 | -$0.34 | -$0.31 | Beat 8.82% | — |
| May 4, 2023 | -$0.37 | -$0.28 | Beat 24.32% | — |
| Mar 22, 2023 | -$0.35 | -$0.31 | Beat 11.43% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026